Delving into the Latest Updates on CLIPS SA with Synapse

概览

关联

1

项与 CLIPS SA 相关的药物

LSCD101

靶点-

作用机制-

在研机构-

原研机构

CLIPS SA

在研适应症-

非在研适应症

老年环 [+1]

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

4

项与 CLIPS SA 相关的临床试验

KCT0004741

/ Completed临床1期

Phase I Study to Evaluate Safety of LSCD101(Cultured Autologous Limbal Epithelial Cell Sheet) Transplantation for Limbal Stem Cell Deficiency

开始日期2020-01-31

申办/合作机构

CLIPS SA

NCT04773431

/ Completed临床1期

Phase I Study to Evaluate Safety of LSCD101(Cultured Autologous Limbal Epithelial Cell Sheet) Transplantation for Limbal Stem Cell Deficiency

Clinical Study Objective:
To evaluate the tolerability and safety after transplantation of LSCD101 in patients with intractable limbal stem cell deficiency
Study Method:
Subjects who finally meet the inclusion/exclusion criteria results of the subject eligibility evaluation will receive transplantation of the investigational product. Adverse drug reaction will be confirmed during 24 weeks after transplantation.

开始日期2020-01-31

申办/合作机构

CLIPS SA

TCTR20190325003

/ Not yet recruiting临床3期

A Multi-national, Multi-center, Randomized, Double-Blind, Active-Controlled, Phase III Study to Investigate the Efficacy and Safety of â€˜GC3107 (BCG Vaccine)â€™ after Intradermal Administration in Healthy Infants

开始日期2019-08-19

申办/合作机构

CLIPS SA

100 项与 CLIPS SA 相关的临床结果

登录后查看更多信息

0 项与 CLIPS SA 相关的专利（医药）

登录后查看更多信息

100 项与 CLIPS SA 相关的药物交易

登录后查看更多信息

100 项与 CLIPS SA 相关的转化医学

登录后查看更多信息